What happened?
A Nature Aging study reports that aging hematopoietic stem cells can develop maladaptive trained immunity, generating myeloid cells that promote chronic inflammation and functional decline in mice. Increasing SIRT3 activity in the stem-cell compartment improved several age-related functional measures in the experimental model.
Why does it matter?
The work suggests that some systemic age-related inflammation may originate high upstream in blood-forming stem cells rather than simply being a passive consequence of damaged tissues.
Healthway perspective
This is preclinical biology. A plausible mechanism and a target in mice are not the same as a safe anti-aging therapy in humans.
What this does not mean
It does not mean SIRT3 supplements or unapproved 'stem-cell rejuvenation' treatments have been shown to extend human life.
Medical News is patient education. Research summaries are independently rewritten by Healthway and do not replace individual diagnosis, treatment decisions or specialist advice.